{"id":7419,"date":"2005-04-18T09:28:16","date_gmt":"2005-04-18T08:28:16","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=7419"},"modified":"2014-05-21T18:39:01","modified_gmt":"2014-05-21T18:39:01","slug":"demand-for-two-originator-arvs-could-soon-exceed-supply","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/7419","title":{"rendered":"Demand for two originator ARVs could soon exceed supply"},"content":{"rendered":"<p><strong>MSF Campaign for Access to Essential Medicines<\/strong><\/p>\n<p><strong>People living with AIDS in developing countries that currently use d4T manufactured by BMS, may face a shortage. This was recently communicated to MSF by BMS, and was confirmed in the Wall Street Journal last week (\u201cDemand for Two AIDS Treatments Could Soon Exceed Supply\u201d, e-drug March 9th). In the article Paul Lalvani, procurement manager for the Global Fund in Geneva, said that some developing countries \u201chave not been able to access the product\u201d.<\/strong><\/p>\n<p>Considering the shortage of the BMS product it is important to note that on March 1st, WHO published a new edition of the prequalification list that included stavudine, and the combination stavudine\/lamivudine from the Indian manufacturer Strides (both 40 mg). The other prequalified option is Cipla\u2019s Triomune, stavudine\/lamivudine\/nevirapine (both 30 and 40 mg). The annual prices for these generic drugs are $51, $142 and $221 respectively (USD). They can be found in the MSF document \u201cUntangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries\u201d, 7th edition, February 2005.<\/p>\n<p>MSF Campaign for Access to Essential Medicines.<br \/>\n<a href=\"http:\/\/www.accessmed-msf.org\">http:\/\/www.accessmed-msf.org<\/a><\/p>\n<p>This case illustrates the importance of having several sources of a drug available to face shortages and production problems. The originator companies alone do not have either the financial interest or the capacity of production to assure supply to developing countries.<\/p>\n<p>* Prices have been adjusted to take into account additional costs.<\/p>\n<p>Further information: <a href=\"mailto:fernando.pascual@geneva.msf.org\">fernando.pascual@geneva.msf.org<\/a><\/p>\n<h3>Comment<\/h3>\n<p><strong>It has been clear for a long time that no single company has the manufacturing capacity or capability to meet the World demand for ARV treatment \u2013 even if funding and infrastucture were immediately in place.<\/strong><\/p>\n<p><strong>This story highlights these concerns and the critical importance of both brand and generic manufacturers supplying HIV medications<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MSF Campaign for Access to Essential Medicines People living with AIDS in developing countries that currently use d4T manufactured by BMS, may face a shortage. This was recently communicated to MSF by BMS, and was confirmed in the Wall Street &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-7419","post","type-post","status-publish","format-standard","hentry","category-treatment-access"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=7419"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/7419\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=7419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=7419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=7419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}